The statements below are read from DEEPAK CHEMTEX LIMITED’s filed results, 3 filed quarters and 5 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed May 30, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H2 FY25Mar 2025 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|
| Sales | 40.6 | 30.9 | 36.7 | -9.5% |
| 31.9 | 24.9 | 31.5 | -1.3% | |
| Operating profit | 8.71 | 6.06 | 5.26 | -39.6% |
| OPM % | 21.5% | 19.6% | 14.3% | -7.1 pp |
| Other income | 1.79 | 0.80 | 2.19 | +22.4% |
| Interest | 0.03 | 0.05 | 0.09 | +175.1% |
| Depreciation | 1.23 | 1.23 | 1.34 | +8.4% |
| Profit before tax | 9.24 | 5.57 | 6.03 | -34.7% |
| Tax % | 25.6% | 22.3% | 31.3% | +5.8 pp |
| Net profit | 6.87 | 4.33 | 4.14 | -39.8% |
| EPS (₹) | 6.50 | 3.99 | 3.81 | -41.4% |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
